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a b s t r a c t
Carbon monoxide (CO), a product of the enzyme heme oxygenase (HO), has been recognized to act as an
atypical neurotransmitter or neuromodulator in the nervous system, and several lines of evidence
suggest that CO may play a role through multiple mechanisms in nociceptive processing. Therefore, the
aim of our study was to assess the interaction between the HO/CO pathway and ATP-sensitive
Kþ channels in hypernociception in response to carrageenan. The electronic von Frey and Randall
Selitto tests were applied before and after intraplantar carrageenan administration. The intraplantar
hemin carrageenan administration (HO substrate) into the right hindpaw elicited an antinociceptive
effect, which was determined to be local because it produced no effect when injected into the
contralateral paw. The administration of a HO pathway inhibitor was capable of potentiating the
hypersensitivity evoked by carrageenan. Among the three different HO products, CO appears to be the
one that attenuated the nociceptive response, whereas biliverdin and iron (II) sulfate failed to cause any
signiﬁcant changes. This blockade of the carrageenan mechanical hyperalgesia induced by the hemin was
antagonized by the administration of glybenclamide, and a combination of hemin and diazoxide
decreased the hyperalgesic action of carrageenan. These results also suggest that an endogenous opioid
system may not be involved because naloxone did not affect the hemin-induced antinociception in the
carrageenan model. Our study provides evidence that the peripheral antinociceptive effect of the HO/CO
pathway may result from the activation of ATP-sensitive Kþ channels.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
Carbon monoxide (CO) has long been considered to be a toxic air
pollutant because of its strong afﬁnity for hemoglobin, which is
more than 200-fold greater than that of oxygen. Although it is well
known that CO is a toxicant, there is considerable evidence that it
acts as an endogenous gas involved in speciﬁc biological actions on
different systems (Ryter and Otterbein, 2004; Wu and Wang, 2005).
Endogenous CO is one of the three products of heme degradation
caused by a family of enzymes called heme oxygenases (HO), the
other two being iron and biliverdin (Maines, 1997). There are three
genetically distinct HO isoforms among which isoforms one (the
inducible HO-1) and two (the constitutive HO-2) are the best
known (Maines, 1997).
CO has been recognized to act as a neurotransmitter or
neuromodulator in the nervous system (Mancuso et al., 2010),
and a growing body of evidence suggests that CO can play an
important role in nociceptive regulation. The ﬁrst study of the CO
effects on pain was published in 1994 (Meller et al., 1994), and the
intraplantar administration of the HO inhibitor ZnDPBG enhanced
the mechanical nociceptor hypersensitivity evoked by intraplantar
carrageenan or formalin administration in a dose-dependent
manner, suggesting that the CO produced by HO plays an anti-
hyperalgesic role in inﬂamed paws (Nascimento and Branco, 2007,
2008; Steiner et al., 2001).
Studies have shown that the HO/CO pathway may play a role in
stimulating guanylate cyclase activity and increases the intracellular
second messenger cyclic guanosine monophosphate (cGMP)
(Dawson and Snyder, 1994; Maines, 1997), which then activates
downstream targets, including cGMP-dependent protein kinases,
ion channels, and receptors. Therefore, a large body of evidence
has suggested that the HO–CO–cGMP pathway can play an important
role in different pain states, including spinal glutamate-induced
pain (Li and Clark, 2002) and experimental inﬂammatory pain
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(Steiner et al., 2001), and the formalin test (Nascimento and Branco,
2007, 2008) has also shown its participation in the acute analgesic
actions of morphine (Li and Clark, 2001). It has been demonstrated
that the activation of protein kinase G by cGMP is necessary for the
opening of ATP-sensitive Kþ channels in analgesia (Sachs et al.,
2004), and many studies have suggested that the opening of the ATP-
sensitive Kþ channels plays an important role in the antinociception
induced by morphine (Rodrigues and Duarte, 2000).
Therefore, the present study was undertaken to determine
whether a speciﬁc ATP-sensitive Kþ channel blocker (glybencla-
mide) or an activator of the Kþ channels (diazoxide) had any
effect on the peripheral antinociception induced by the HO/CO
pathway.
2. Materials and methods
2.1. Animals
The experiments were performed on 1807250 g male Wistar
rats (n¼5 or 6 animals per group). The animals were housed in a
temperature-controlled room (23þ18C) with controlled humidity
(40–60%) and on an automatic 12 h light/dark cycle (06.007
18.00 h). All the testing was conducted during the light phase
(07.00713.00 h). Food and water were freely available until the
beginning of the experiments. At the end of the experiments, the
rats were euthanized using an overdose of halothane anesthetic.
All the procedures were conducted in accordance with the
National Institutes of Health Guidelines for the Care and Use of
Laboratory Animals and the recommendations of the International
Association for the Study of Pain (Zimmermann, 1983) and were
approved by the Ethics Committee of the Federal University of
Alfenas, protocol # 390/2012.
2.2. Antinociceptive analysis
Hypernociception was induced in the hindpaw by the admin-
istration of an intraplantar carrageenan suspension (100 μg) and
was measured according to the paw pressure tests of Randall
Selitto (Randall and Selitto, 1957) and the electronic von Frey
method (Vivancos et al., 2004).
In the Randall Selitto test, an analgesy-meter with a cone-
shaped paw-presser with a rounded tip, which applies a linearly
increasing force to the plantar surface of the paw, was used. The
weight in grams (g) required to elicit nociceptive responses such
as paw ﬂexion or struggling was deﬁned as the nociceptive
threshold. A cut-off value of 300 g was used to prevent damage
to the paws.
In the electronic von Frey method, the rats were placed in
acrylic cages (122017 cm3) with wire grid ﬂoors 30 min
before the testing began. The test consisted of evoking a hindpaw
ﬂexion reﬂex with a hand-held force transducer adapted with a
polypropylene tip (Insight Ltd., Brazil). A trained investigator
applied the tip between the distal footpads with a gradual increase
in pressure. The stimulus was discontinued, and the intensity was
recorded at the moment the paw was withdrawn. This endpoint
was characterized by a clear ﬂinch response following the paw
withdrawal.
In both tests, the nociceptive threshold was always (except
when indicated) measured in the right hindpaw and determined
by the average of three consecutive trials recorded before and 3 h
after the carrageenan injection. The results were calculated by the
difference between these two averages (Δ of nociceptive threshold)
and expressed as grams.
2.3. Experimental protocol
Hemin was administered subcutaneously into the right hind-
paw 1 h after a local carrageenan injection, and the HO inhibitor
was administered 5 min before the carrageenan administration
(Steiner et al., 2001). In the protocol used to determine whether
hemin was acting at central sites, the carrageenan was injected
into both hindpaws while the hemin was administered 1 h later
into the left or right paw (Alves et al., 2004a; Rodrigues and
Duarte, 2000). The sulfonylurea (glybenclamide) was administered
1 h 20 min after the hemin, whereas the activator of Kþ channels
diazoxide and the opioid receptor antagonist naloxone were
injected 2 h 45 min after the carrageenan (Alves et al., 2004b;
Rodrigues et al., 2005). The opioid agonist fentanyl was adminis-
tered 2 h 20 min after the carrageenan (Rodrigues et al., 2005).
2.4. Chemicals
Chemicals and suppliers: Carrageenan (Sigma, USA); Hemin
(Sigma, USA); Biliverdin Hydrochloride (Frontier Scientiﬁc, USA);
Iron (II) Sulfate (Isofar, Brazil); Tin protoporphyrin IX dichloride
(Tocris, USA); Fentanest Citrate de Fentanila (fentanyl) 0.05 mg
(Cristália, Brazil); Glybenclamide (Sigma, USA); Diazoxide (Sigma,
USA); Naloxone Hydrochloride (Cristália, Brazil); Na2CO3 (Dinamica,
Brazil); and Tween 80. The doses of drugs used in the present study
are in agreement with the doses commonly used in other reports
that injected these compounds peripherally. The carrageenan, iron
(II) sulfate, fentanyl and naloxone were dissolved in isotonic saline.
The hemin, tin protoporphyrin IX dichloride and biliverdin were
dissolved in sodium carbonate buffer (50 mmol), and the glybencla-
mide and diazoxide were dissolved in a solution of Tween 80 (2% in
saline).
2.5. Statistical analysis
The data were plotted using the GraphPad software program
(version 5.0) and were expressed as the means7S.E.M. The
statistical analyses were carried out by one-way or two-way
analysis of variance (ANOVA) followed by Tukey0s test for multiple
comparisons. Probabilities less than 5% (Po0.05) were considered
to be statistically signiﬁcant.
3. Results
3.1. Effects of hemin on carrageenan-induced hypernociception
In the animals post-treated with vehicle, the intraplantar
carrageenan administration induced the development of mechan-
ical hypernociception when compared with the administration of
the saline both in the electronic von Frey test (F5,35¼48.97;
Po0.01 and Po0.001; Fig. 1A) and in the Randall Selitto test
(F5,35¼38.18; Po0.05 and Po0.001; Fig. 1B). This hypernocicep-
tion evaluated by the electronic von Frey test was inhibited by the
hemin, substrate used to induce HO pathway, administered in the
same paw at the doses of 19.5 mg and 65 mg and was blocked by
the dose of 195 mg (Po0.001; Fig. 1A). Similar results were
observed in the Randall Selitto test, in that the hemin reduced
the mechanical hypernociception at a dose of 65 mg and blocked
this response at a dose of 195 mg (Po0.001; Fig. 1B). Hemin at the
dose of 65 mg, when administered into the left paw, did not
produced an anti-hypernociceptive effect in the right paw
(von Frey test: F3,21¼101.0; Fig. 2A; Randall Selitto: F3,22¼154.6;
Fig. 2B).
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3.2. Effect of tin protoporphyrin IX dichloride on
carrageenan-induced hypernociception
A statistical analysis of Fig. 3 (electronic von Frey) shows the
occurrence of the responses to statistically signiﬁcant variable times
(F5, 25¼266.4, Po0.0001) and nociceptive thresholds (F5, 25¼565.8,
Po0.0001) and the interactions between these variables (F5, 25¼
40.63; Po0.0001). We observed in animals post-treated with vehicle
that the intraplantar carrageenan administration induced the devel-
opment of mechanical hypernociception when compared with the
administration of the saline (Po0.05 and Po0.001), and this response
was enhanced in the groups treated with tin protoporphyrin IX
dichloride, a HO inhibitor, at the concentrations of 150 and 300 mg
(Po0.05 and Po0.001), reaching greater signiﬁcance at 240 min
(Po0.001). The group pre-treated with the HO before the intraplantar
administration of the saline solution did not demonstrate any altera-
tion in mechanical hypernociception. Fig. 4 (Randall Selitto) shows
that in the animals post-treated with the vehicle, the intraplantar
carrageenan administration induced the development of mechanical
hypernociception when compared with the administration of saline
(F5,35¼27.27; Po0.001) and that the hypersensitivity evoked by the
carrageenan was potentiated by the HO inhibitor (300 mg) (Po0.05).
We also observed that the intraplantar tin protoporphyrin IX
dichloride administration did not change the mechanical nociception
after the saline solution injection.
3.3. Effect of biliverdin or iron (II) sulfate on carrageenan-induced
hypernociception
In the animals post-treated with vehicle, the intraplantar
carrageenan administration induced the development of mechan-
ical hypernociception when compared with the administration of
the saline both in the electronic von Frey test (F5,35¼159.5;
Po0.001; Fig. 5A; F5,35¼212.3; Po0.001; Fig. 6A) and in the
Randall Selitto test (F5,34¼37.25; Po0.001; Fig. 5B; F5,35¼44.05;
Po0.001; Fig. 6B). This hypernociception was not altered by the
administration in the same paw of biliverdin or iron (II) sulfate,
drugs used to verify the involvement of other products of HO/CO
pathway in the antinociceptive response.
3.4. Effect of glybenclamide on the anti-hypernociceptive effect of
hemin
In the animals post-treated with the vehicle, the intraplantar
carrageenan administration induced the development of mechanical
Fig. 1. Effect of local administration of hemin or vehicle (Na2CO3) on the mechan-
ical nociceptor hypersensitivity responses to carrageenan. The mechanical evalua-
tion of the intensity of hypernociception (Δ withdrawal threshold in grams) was
performed by the electronic von Frey method (Fig. 1A) and Randall Selitto (Fig. 1B),
3 h after administration of carrageenan (n¼6; mean7S.E.M). nPo0.01 or
nnPo0.001 in the electronic von Frey tests or nPo0.05 or nnPo0.001 in the
Randall Selitto compared Saline/Vehicle; ##Po0.001 compared Carrageenan/Vehicle
(One-way ANOVA, followed by Tukey0s test).
Fig. 2. Exclusion of outside paw antinociceptive effect of hemin. The mechanical
evaluation of hypernociception intensity (Δ withdrawal threshold in grams) was
performed in the electronic von Frey test (Fig. 2A) and Randall Selitton test
(Fig. 2B), 3 h after carrageenan administration (n¼6; mean7S.E.M). nnPo0.001
compared Saline/Vehicle; ##Po0.001 compared Carrageenan/Vehicle (One-way
ANOVA, followed by Tukey0s test). Abbreviations: L paw, left paw; R paw, right paw.
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hypernociception when compared with the administration of the
saline both in the electronic von Frey test (F6,41¼109.0; Po0.001;
Fig. 7A) and the Randall Selitto test (F6,41¼77.93; Po0.001; Fig. 7B).
The post-treatment of the animals with the ATP-sensitive Kþ channel
antagonist glybenclamide inhibited (Po0.001; Fig. 7A and B) the
peripheral antinociception caused by the administration of hemin at
65 mg (Po0.05 or Po0.001; Fig. 7A and B) in both the tests. The
animals post-treated with glybenclamide after the intraplantar saline
and vehicle administration did not demonstrate any alterations in
their mechanical nociceptive response.
3.5. Effect of the combination of diazoxide with hemin on
carrageenan-induced hypernociception
The administration of diazoxide (20, 60 or 120 μg) an activator
of the Kþ channels into the right hind paw antagonized the
carrageenan-induced hypernociception (F3,23¼118.0; Po0.001;
Fig. 8A; F3,23¼38.35; Po0.05 and Po0.001; Fig. 8B). The treat-
ment with the minimum doses of diazoxide (20 μg) or of hemin
(19.5 μg) produced an anti-hypernociceptive effect (F4,29¼80,90;
Po0.001; Fig. 9A; F4,29¼84,22; Po0.001; Fig. 9B), and joint
administration of these drugs caused a signiﬁcant increase in the
anti-hypernociceptive effect of hemin in both the tests (Po0.001;
Fig. 9A and B) after the induction of the mechanical hypernocicep-
tion by the pre-treatment with carrageenan (Po0.001; Fig. 9A
and B).
3.6. Effect of naloxone on hemin-induced anti-hypernociception
The pre-treatment with carrageenan induced the development
of mechanical hypernociception when compared with the saline
administration in the animals post-treated with the vehicle
(F7,47¼41,40; Po0.001; Fig. 10A; F7,47¼87.92; Po0.001; Fig. 10B;
F7,47¼67.71; Po0.05 and Po0.001; Fig. 11A; F7,47¼32.80;
Po0.001; Fig. 11B) and this hypernociception was inhibited by
the post-treatment with fentanyl at 1.5 μg (opioid agonist used as
Fig. 3. Effect of Tin protoporphyrin IX dichloride (HO inhibitor) or vehicle on the
mechanical nociceptor hypersensitivity response to injection of carrageenan. The
intensity of mechanical hypersensitivity was measured by the electronic von Frey test
with 30, 60, 120, 180 or 240 min after injection of carrageenan (n¼6; mean7S.E.M).
nPo0.05 or nnPo0.001 compared Saline/Vehicle; #Po0.05 or ##Po0.001 compared
Carrageenan/Vehicle (Two-way ANOVA followed by tukey0s test).
Fig. 4. Effect of local administration of the Tin protoporphyrin IX dichloride (HO
inhibitor) or vehicle on the mechanical nociceptor hypersensitivity. The mechanical
evaluation of the intensity of hypernociception (Δ withdrawal threshold in grams)
was performed by the Randall Selitto test, 3 h after administration of carrageenan
(n¼6; mean7S.E.M). nnPo0.001 compared Saline/Vehicle; #Po0.05 compared
Carrageenan/Vehicle (One-way ANOVA, followed by tukey0s test).
Fig. 5. Effect of local administration of Iron (II) sulfate or vehicle on nociceptive
response to carrageenan. The evaluation of the mechanical hypernociception (Δ
withdrawal threshold in grams) was performed by the electronic von Frey method
(Fig. 5A, n¼6) and Randall Selitto test (Fig. 5B, n¼5), 3 h after administration of
carrageenan (mean7S.E.M). nnPo0.001 compared Saline/Vehicle (One-way
ANOVA, followed by Tukey0s test). Abbreviation: Iron (II), Iron (II) sulfate.
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positive control) or hemin at 65 μg (Po0.001; Figs. 10A and B; 11A
and B). The post-treatment with naloxone, drug opioid receptor
antagonist, caused a reduction in the anti-hypernociceptive
response caused by the fentanyl (Po0.001; Fig. 10A and B) but
did not affect the anti-hypernociceptive response to hemin
(Fig. 11A and B).
4. Discussion and conclusions
The present study provides evidence that the sulfonylurea
glibenclamide could reverse the peripheral antinociceptive effect
induced by the HO/CO pathway.
The antinociceptive effect of the HO/CO pathway in experi-
mental pain models has been described by some authors in the
formalin test (Nascimento and Branco, 2007; Yamamoto and
Nozaki-Taguchi, 1995) and in inﬂammatory models (Steiner et al.,
2001).
We demonstrated in this study that the administration of hemin
(HO substrate) plays a mechanical anti-hypersensitivity role during
carrageenan-evoked inﬂammation. It was also observed that treat-
ment with the potent inhibitor of HO tin protoporphyrin
IX dichloride enhanced the mechanical hypernociception induced
by the intraplantar carrageenan administration. This result
corroborates with previous reports on the antinociceptive role of
the HO/CO pathway during carrageenan evoked inﬂammation and
in the formalin test (Nascimento and Branco, 2007; Steiner et al.,
2001). In accordance with this, we determined whether subcuta-
neous injections of biliverdin and free iron, other HO activity
products, could be responsible for the nociceptive changes observed
in the pathway induction. The result of these treatments shows that
iron (II) sulfate (a substance containing iron in its composition) and
biliverdin have no effect on the nociceptive response, suggesting that
biliverdin and iron are not involved in nociception during the
induction of hyperalgesia by the subcutaneous carrageenan injection.
To exclude the central effects of the drugs, many strategies can be
used (Stein, 1993). In the present study, we used the strategy of
evaluating the efﬁcacy of ipsi- versus contralateral paw administra-
tion because the route and site of administration would be the same.
Hemin at a dose of 65 μg was ineffective when administered into the
contralateral paw, suggesting that at this dose the hemin has a
peripheral site of action in inﬂamed tissue.
Fig. 6. Effect of local administration of Biliverdine on nociceptive response to
carrageenan. The evaluation of the mechanical hypernociception (Δ withdrawal
threshold in grams) was performed by the method of electronic von Frey (Fig. 6A)
and Randall Selitto test (Fig. 6B), 3 h after administration of carrageenan (n¼6;
mean7S.E.M). nnPo0.001 compared Saline/Vehicle (One-way ANOVA, followed by
Tukey0s test). Fig. 7. Effect of antagonism induced by intraplantar administration of glybencla-
mide on the peripheral antinociception produced by hemin. The mechanical
evaluation of the intensity of hypernociception (Δ withdrawal threshold in grams)
was performed in the by the method of electronic von Frey (Fig. 7A) and Randall
Selitto test. (Fig. 7B) 3 h after administration of carrageenan (n¼6; mean7S.E.M).
nnPo0.001 compared Saline/Vehicle/Vehicle; #Po0.05 or ##Po0.001 compared
Carrageenan/Vehicle/Vehicle; þ þPo0.001 compared Carrageenan/Hemin/Vehicle
(One-way ANOVA, followed by tukey0s test). Abbreviation: Glyben, glybenclamide.
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The peripheral analgesics that block ongoing hypernociception
appear to restore the normal high receptor threshold via opening
the KþATP channels with a consequent increase in the Kþ current.
It is known that, depending on the biological system, cGMP
modulates ion channels directly (Dowling, 1996) or indirectly
(via protein kinase G stimulation and opening of KþATP) (Han
et al., 2001, Segawa et al., 2001). Considerable evidence has shown
that CO stimulates guanylate cyclase activity and increases the
intracellular second messenger cGMP (Dawson and Snyder, 1994;
Maines, 1997). Our study elucidated the participation of the
ATP-sensitive Kþ channel in the HO–CO pathway-induced anti-
nociception, where the local peripheral administration of the
ATP-sensitive Kþ channel antagonist glybenclamide signiﬁcantly
reversed the antinociceptive activity of the hemin. There have
been many reports on the fact that glybenclamide speciﬁcally
blocks the ATP sensitive Kþ channel, with no effects on other
types of Kþ channels such as the Ca2þ-activated Kþ channel and
the voltage gated potassium channels (Segawa et al., 2001; Smith,
1984, Soares and Duarte, 2001). In this way, our results suggest
that the modulation of the ATP-sensitive Kþ channel may repre-
sent an important step in the peripheral mechanism of antinoci-
ceptive action of the HO-CO pathway.
Consistent with this ﬁnding, the studies of Foresti et al. (2004)
showed that the vasorelaxant action of the CO released by tricar-
bonylchloro-(glycinato)ruthenium(II) (CORM-3) in aortic tissues
previously contracted with phenylephrine was also signiﬁcantly
reduced after incubation with glybenclamide, thereby indicating a
possible role for the ATP-sensitive Kþ channel in CO action.
We also observed that the peripheral administration of the
activator of Kþ channels diazoxide produced antinociception and
that the combination of low doses of hemin and diazoxide
exhibited a decrease in the hyperalgesic action of carrageenan.
Considering this, it is likely that the local peripheral administra-
tion of hemin could have a synergistic interaction with the
activation of Kþ channels. In the present work, it was also
demonstrated that the pretreatment with naloxone (opioid
Fig. 8. Effect of administration of activating Kþchannels (diazoxide) or vehicle
(Tween 80-2% in saline) on hyperalgesia induced by carrageenan injection. The
mechanical evaluation of the intensity of hypernociception (Δ withdrawal threshold
in grams) was performed in the by the method of electronic von Frey (Fig. 8A) and
Randall Selitto test (Fig. 8B) 3 h after administration of carrageenan (n¼6; mean7S.
E.M). #Po0.05 or ##Po0.001 compared Carrageenan/Vehicle (One-way ANOVA,
followed by Tukey0s test).
Fig. 9. Effect of the combination of hemin and diazoxide on the hyperalgesic action
of carrageenan. The mechanical evaluation of the intensity of hypernociception
(Δwithdrawal threshold in grams) was performed in the by the method of electronic
von Frey (Fig. 9A) and Randall Selitto test (Fig. 9B), 3 h after administration of
carrageenan (n¼6; mean7S.E.M). nnPo0.001 compared Saline/Vehicle/Vehicle;
##Po0.001 compared Carrageenan/Vehicle/Vehicle; þ þPo0.001 compared Carra-
geenan/Hemin/Vehicle (One-way ANOVA, followed by Tukey0s test).
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receptor antagonists) signiﬁcantly reduced the analgesic activity of
fentanyl, but no signiﬁcant reduction in the analgesic hemin was
observed, suggesting that the analgesic activity of hemin is not
mediated by the opioid receptors.
5. Conclusions
In summary, our results support the hypothesis that the
peripheral antinociceptive effect of the HO/CO pathway is asso-
ciated with ATP-sensitive Kþ channel activation. The present
observations will further contribute to a better understanding of
the peripheral antinociceptive mechanism of action induced by
this pathway, which will provide support for future investigations.
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